HUT39439A - Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents - Google Patents
Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agentsInfo
- Publication number
- HUT39439A HUT39439A HU853828A HU382885A HUT39439A HU T39439 A HUT39439 A HU T39439A HU 853828 A HU853828 A HU 853828A HU 382885 A HU382885 A HU 382885A HU T39439 A HUT39439 A HU T39439A
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- active agents
- compositions containing
- producing new
- thiazolidinedione derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP1984/000466 WO1986002073A1 (en) | 1984-10-03 | 1984-10-03 | Thiazolidinedione derivatives, process for their preparation, and pharmaceutical composition containing same |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT39439A true HUT39439A (en) | 1986-09-29 |
HU194199B HU194199B (en) | 1988-01-28 |
Family
ID=13818418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU853828A HU194199B (en) | 1984-10-03 | 1985-10-02 | Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents |
Country Status (4)
Country | Link |
---|---|
HU (1) | HU194199B (en) |
SU (1) | SU1496634A3 (en) |
WO (1) | WO1986002073A1 (en) |
ZA (1) | ZA857448B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988009661A1 (en) * | 1987-06-10 | 1988-12-15 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
CN101454005B (en) | 2006-03-16 | 2013-01-02 | 新陈代谢解决方案开发公司 | Thiazolidinedione analogues for the treating metabolic inflammation mediated disease |
JP5149271B2 (en) | 2006-03-16 | 2013-02-20 | メタボリック ソリューションズ ディベロップメント カンパニー, エルエルシー | Thiazolidinedione analogs for treating hypertension and for lowering lipids |
PL2203433T3 (en) | 2007-09-14 | 2013-04-30 | Metabolic Solutions Dev Co Llc | 5-(4-(2-(3-methoxyphenyl)-2-oxoethoxy)benzyl)thiazolidine-2,4-dione for use in treating diabetes |
US8304441B2 (en) | 2007-09-14 | 2012-11-06 | Metabolic Solutions Development Company, Llc | Thiazolidinedione analogues for the treatment of metabolic diseases |
MX2012006725A (en) | 2009-12-15 | 2012-06-28 | Metabolic Solutions Dev Co Llc | Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
JPS5697277A (en) * | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
JPS58118577A (en) * | 1982-01-07 | 1983-07-14 | Takeda Chem Ind Ltd | Thiazolidine derivative |
JPS5948471A (en) * | 1982-09-10 | 1984-03-19 | Takeda Chem Ind Ltd | Thiazolidine derivative |
-
1984
- 1984-10-03 WO PCT/JP1984/000466 patent/WO1986002073A1/en unknown
-
1985
- 1985-09-26 ZA ZA857448A patent/ZA857448B/en unknown
- 1985-10-02 HU HU853828A patent/HU194199B/en not_active IP Right Cessation
- 1985-10-02 SU SU853966456A patent/SU1496634A3/en active
Also Published As
Publication number | Publication date |
---|---|
SU1496634A3 (en) | 1989-07-23 |
ZA857448B (en) | 1987-05-27 |
HU194199B (en) | 1988-01-28 |
WO1986002073A1 (en) | 1986-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT37781A (en) | Process for producing 1-fluorphenyl-butyl-4-/2-pirimidinyl/-piperazine derivatives and pharmaceutical compositions containing them as active agents | |
HUT34462A (en) | Process for producing oxooxazolidinyl-benzene derivatives and pharmaceutical compositions containing them as active ingredients | |
HUT46710A (en) | Process for producing peptode derivatives and pharmaceutical compositions containing them as active components | |
HUT40624A (en) | Process for producing indol derivatives and pharmaceutical compositions containing them as active agents | |
HUT39444A (en) | Process for preparing pyridine derivatives and pharmaceutical compositions containing such compounds as active substances | |
HUT47274A (en) | Process for producing terciary hydroxy-alkyl-xantines and pharmaceutical compositions containing them as active components | |
HUT47090A (en) | Process for producing new thiazol derivatives and pharmaceutical compositions of leukotrinen-antagonistic activity containing them as active components | |
HUT45252A (en) | Process for producing imidazo-pyridine derivatives and pharmaceutical compositions containing them as active components | |
HUT41800A (en) | Process for producing new beta-lactame antibiotica and pharmaceutical compositions containing them as active agents | |
HUT48247A (en) | Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components | |
HUT38897A (en) | Process for producing pharmaceutically active substituted benzamides and pharmaceutical compositions containing them as active agents | |
HUT46930A (en) | Process for producing aminoglycoside-steroides and pharmaceutical compositions containing them as active components | |
HUT48251A (en) | Process for producing new xantin derivatives and pharmaceutical compositions containing them as active components | |
HUT55394A (en) | Process for producing pirrolidino-piperazine-dion derivatives and pharmaceutical compositions containing them as active components | |
HUT41784A (en) | Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents | |
HUT43573A (en) | Process for producing azolyl-cyclopropyl-ethanol derivatives and compositions containing them as active agents | |
HUT39437A (en) | Process for producing new morpholinol derivatives and pharmaceutical compositions containing them as active agents | |
HUT43848A (en) | Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents | |
HUT52493A (en) | Process for producing benzopiranol derivatives and pharmaceutical compositions containing them as active components | |
HUT39450A (en) | Process for producing imidazobicyclic compounds and pharmaceutical compositions containing them as active agents | |
HUT34007A (en) | Process for preparing 5-acyl-2-/1h/-pyridinine derivatives and pharmaceutical compositions containing thereof as active substaces | |
HUT47096A (en) | Process for producing 1,2-dithiol-3-thion derivatives and pharmaceutical compositions containing them as active components | |
HUT39451A (en) | Process for producing 6-substituted mitomycin derivatives and pharmaceutical compositions containing them as active agents | |
HUT39439A (en) | Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents | |
HUT41376A (en) | Insecticide compositions containing phenyl-hidrazine derivatives as active agents and process for producing the active agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HU90 | Patent valid on 900628 | ||
HMM4 | Cancellation of final prot. due to non-payment of fee |